Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review.
Anastasios Kyriazoglou(Alexandra Hospital), Amanda Psyrri(National and Kapodistrian University of Athens), Anna Boulouta(National and Kapodistrian University of Athens), Anastasios Pantazopoulos(University General Hospital Attikon), Μaria Anastasiou(National and Kapodistrian University of Athens), George Kavourakis(National and Kapodistrian University of Athens), Maria Kirkasiadou(National and Kapodistrian University of Athens), Ioannis Kotsantis(National and Kapodistrian University of Athens), Myrto Moutafi(University General Hospital Attikon), Evangelos Zazas(National and Kapodistrian University of Athens), Panagiota Economopoulou(National and Kapodistrian University of Athens), Chrysanthi Nasiadi(University General Hospital Attikon), Niki Gavrielatou(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618
Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.
|Head & Neck|2009|265
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study
|Annals of Oncology|2022|148
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
|Laboratory Investigation|2022|141
Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-Positive Oropharyngeal Squamous Carcinoma Cells
|Molecular Cancer Research|2010|120